Sign in
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD
Peter A. Campochiaro, MD
Updates from the Field
2020
Intravitreal Injections: Logistics, Safety, and Pearls
Andrew A. Moshfeghi, MD, MBA, FASRS
Webinars and Journal Clubs
2018
The Changing Avastin Landscape
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2019
Category: Pharmacology